Alkeon Capital Management
PASG icon

Alkeon Capital Management’s Passage Bio PASG Stock Holding History

Alkeon Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,250
Closed -$13.8M – 157
2020
Q2 		$13.8M Hold
25,250
– – 0.03% 124
2020
Q1 		$7.95M Buy
+25,250
New +$7.9M 0.03% 117

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alkeon Capital Management's PASG Position: Q3 2020 in Review

Alkeon Capital Management sold out of Passage Bio (PASG) in Q3 2020, closing a stake of 25,250 shares — an estimated $13.8M sold.

Alkeon Capital Management first reported a position in PASG in Q1 2020 and held it in 2 quarters. The position peaked at $13.8M in Q2 2020. 70 funds tracked by Wall St. Rank hold PASG as of Q3 2020.

  • Alkeon Capital Management reported no remaining Passage Bio position as of Q3 2020 after selling out during the quarter.
  • Alkeon Capital Management sold 25,250 Passage Bio shares in Q3 2020, an estimated $13.8M.
  • Alkeon Capital Management first reported a position in Passage Bio in Q1 2020 and held it in 2 quarters.
  • Alkeon Capital Management's Passage Bio position peaked at $13.8M in Q2 2020.
  • 70 funds tracked by Wall St. Rank held Passage Bio as of Q3 2020.

Based on Alkeon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.